MedTrace Logo

Local Sensory Nerve Block in the Treatment of Vestibular Migraine

NCT05472675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2025-06-04

No results posted yet for this study

Summary

There is no standard approach to the treatment of vestibular migraine. Agents used in the treatment of migraine are frequently used. In treating migraine, local anesthetic agents, nerve-blocking methods, and botulinum toxin local injection is commonly applied, and successful results are obtained. Adapting the nerve-blocking method used in the treatment of migraine to the treatment of vestibular migraine is the purpose of the study.

Conditions

  • Vestibular Migraine

Interventions

PROCEDURE

Botulinum toxin and bupivacain

Botulinum toxin A AND bupivacain( local anesthetic)

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • Fazıl N Ardıç, MD · Head of Department

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05472675 on ClinicalTrials.gov